The Effect of Vitamin c on Preventing Complex Regional Pain Syndrome (CRPS Type I) Following Ankle Fracture

Sponsor
Rabin Medical Center (Other)
Overall Status
Unknown status
CT.gov ID
NCT01338129
Collaborator
(none)
100
1
2
34.1
2.9

Study Details

Study Description

Brief Summary

The use of prophylactic treatment with vitamin c may prevent complex regional pain syndrome (CRPS)

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: vitamin c
  • Drug: placebo
N/A

Detailed Description

There are several studies similar in wrist fracture.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Care Provider, Investigator)
Primary Purpose:
Prevention
Official Title:
The Effect of Vitamin c on Preventing Complex Regional Pain Syndrome (CRPS Type I) Following Ankle Fracture, Prospective Double Blind Study
Study Start Date :
Apr 1, 2011
Anticipated Primary Completion Date :
Dec 1, 2013
Anticipated Study Completion Date :
Feb 1, 2014

Arms and Interventions

Arm Intervention/Treatment
Experimental: vitamin c

administration of vitamin c for 45 days following ankle fracture operation

Dietary Supplement: vitamin c
1000 mg of vitamin c for 45 days
Other Names:
  • ascorbic acid
  • Placebo Comparator: placebo

    placebo pills

    Drug: placebo
    placebo pills

    Outcome Measures

    Primary Outcome Measures

    1. CRPS incidence [6 months]

      the incidence of CRPS (according to the IASP or Bruehl diagnostic cruteria) in both population following the fracture will be record and compared

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • ankle fracture within 3 weeks after the fracture
    Exclusion Criteria:
    • pregnant or lactating woman

    • open fracture

    • already treated with vitamin c

    • chronic renal failure

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Beilinson, Rabin Medical Center, Petah Tikva, Israel

    Sponsors and Collaborators

    • Rabin Medical Center

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT01338129
    Other Study ID Numbers:
    • RMC116131CTIL
    First Posted:
    Apr 19, 2011
    Last Update Posted:
    Apr 19, 2011
    Last Verified:
    Mar 1, 2011

    Study Results

    No Results Posted as of Apr 19, 2011